Home / LLY / Financial Statements

Eli Lilly and Company (LLY)

Healthcare | Drug Manufacturers General
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 12,728,500,000 13,532,800,000 11,439,100,000 11,302,800,000
Cost of Revenue 2,224,200,000 2,403,800,000 2,170,800,000 2,170,200,000
Gross Profit 10,504,300,000 11,129,000,000 9,268,300,000 9,132,600,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 2,362,200,000 2,424,500,000 2,099,800,000 2,002,900,000
Operating Expenses 5,095,900,000 5,331,200,000 4,833,900,000 4,828,500,000
Operating Income 5,408,400,000 5,797,800,000 4,434,400,000 4,304,100,000
Interest Expense 243,700,000 224,700,000 192,700,000 183,600,000
Income Before Tax 3,456,100,000 5,038,700,000 1,588,400,000 3,517,200,000
Income Tax Expense 696,800,000 628,900,000 618,100,000 550,200,000
Net Income 2,759,300,000 4,409,800,000 970,300,000 2,967,000,000
Per Share
EPS 3.07 4.88 1.08 3.29
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue 45,042,700,000 34,124,100,000 28,541,400,000 28,318,400,000 24,539,800,000
Cost of Revenue 8,418,300,000 7,082,200,000 6,629,800,000 7,312,800,000 5,483,300,000
Gross Profit 36,624,400,000 27,041,900,000 21,911,600,000 21,005,600,000 19,056,500,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 8,593,800,000 6,941,200,000 6,440,400,000 6,431,600,000 6,121,200,000
Operating Expenses 19,584,400,000 16,254,600,000 13,631,200,000 13,457,500,000 12,206,900,000
Operating Income 12,899,000,000 10,325,400,000 7,127,300,000 6,357,100,000 6,058,000,000
Interest Expense 780,600,000 485,900,000 331,600,000 339,800,000 359,600,000
Income Before Tax 12,680,400,000 6,554,600,000 6,806,400,000 6,155,500,000 7,229,900,000
Income Tax Expense 2,090,400,000 1,314,200,000 561,600,000 573,800,000 1,036,200,000
Net Income 10,590,000,000 5,240,400,000 6,244,800,000 5,581,700,000 6,193,700,000
Per Share
EPS 11.76 5.83 6.93 6.15 6.47
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Cash and Cash Equivalents 3,268,400,000 2,818,600,000 2,067,000,000 3,818,500,000
Short Term Investments 154,800,000 109,100,000 144,800,000 90,100,000
Net Receivables 13,275,400,000 11,336,200,000 8,558,900,000 8,127,200,000
Inventory 7,589,200,000 5,772,800,000 4,309,700,000 3,886,000,000
Total Current Assets 32,739,700,000 25,727,000,000 18,034,500,000 18,452,400,000
Property Plant Equipment 17,102,400,000 12,913,600,000 10,144,000,000 8,985,100,000
Goodwill and Intangibles 11,936,600,000 11,846,300,000 11,279,600,000 11,583,900,000
Total Assets 78,714,900,000 64,006,300,000 49,489,800,000 48,806,000,000
Liabilities
Account Payables 3,228,600,000 2,598,800,000 1,930,600,000 1,670,600,000
Short Term Debt 5,117,100,000 6,904,500,000 1,501,100,000 1,538,300,000
Total Current Liabilities 28,376,600,000 27,293,200,000 17,138,200,000 15,052,700,000
Long Term Debt 28,527,100,000 18,320,800,000 14,737,500,000 15,346,400,000
Total Liabilities 64,443,300,000 53,142,600,000 38,714,400,000 39,651,200,000
Shareholders Equity
Retained Earnings 13,545,000,000 10,312,300,000 10,042,600,000 8,958,500,000
Total Shareholders Equity 14,192,100,000 10,771,900,000 10,649,800,000 8,979,200,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Assets
Cash and Cash Equivalents 3,268,400,000 2,818,600,000 2,067,000,000 3,818,500,000 3,657,100,000
Short Term Investments 154,800,000 109,100,000 144,800,000 90,100,000 24,200,000
Net Receivables 13,275,400,000 11,336,200,000 8,558,900,000 8,127,200,000 6,929,000,000
Inventory 7,589,200,000 5,772,800,000 4,309,700,000 3,886,000,000 3,980,300,000
Total Current Assets 32,739,700,000 25,727,000,000 18,034,500,000 18,452,400,000 17,462,100,000
Property Plant Equipment 17,102,400,000 12,913,600,000 10,144,000,000 8,985,100,000 8,681,900,000
Goodwill and Intangibles 11,936,600,000 11,846,300,000 11,279,600,000 11,583,900,000 11,216,500,000
Total Assets 78,714,900,000 64,006,300,000 49,489,800,000 48,806,000,000 46,633,100,000
Liabilities
Account Payables 3,228,600,000 2,598,800,000 1,930,600,000 1,670,600,000 1,606,700,000
Short Term Debt 5,117,100,000 6,904,500,000 1,501,100,000 1,538,300,000 8,700,000
Total Current Liabilities 28,376,600,000 27,293,200,000 17,138,200,000 15,052,700,000 12,481,600,000
Long Term Debt 28,527,100,000 18,320,800,000 14,737,500,000 15,346,400,000 16,586,600,000
Total Liabilities 64,443,300,000 53,142,600,000 38,714,400,000 39,651,200,000 40,807,900,000
Shareholders Equity
Retained Earnings 13,545,000,000 10,312,300,000 10,042,600,000 8,958,500,000 7,830,200,000
Total Shareholders Equity 14,192,100,000 10,771,900,000 10,649,800,000 8,979,200,000 5,641,600,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Activities
Net Income 10,590,000,000 5,240,400,000 6,244,800,000 5,581,700,000
Depreciation & Amortization 1,766,600,000 1,527,300,000 1,522,500,000 1,547,600,000
Stock Based Compensation 645,600,000 628,500,000 371,100,000 342,800,000
Change in Working Capital -5,385,000,000 -3,055,000,000 -14,500,000 -1,022,600,000
Operating Cash Flow 8,817,900,000 4,240,100,000 7,084,400,000 7,260,700,000
Investing Activities
Capital Expenditure -8,403,600,000 -7,392,100,000 -2,484,000,000 -1,873,200,000
Investments -5,057,800,000 -7,392,100,000 -2,484,000,000 -1,309,800,000
Investing Cash Flow -9,301,500,000 -7,152,700,000 -3,261,600,000 -2,762,300,000
Financing Activities
Debt Repayment 8,901,100,000 -8,649,900,000 -1,560,000,000 -1,905,400,000
Common Stock Issued/Repurchased -2,500,000,000 -750,000,000 -1,500,000,000 -1,250,000,000
Dividends Paid -4,680,400,000 -4,069,300,000 -3,535,800,000 -3,086,800,000
Financing Cash Flow 1,230,100,000 3,495,600,000 -5,406,700,000 -4,131,300,000
Summary
Free Cash Flow 414,300,000 -3,152,000,000 4,600,400,000 5,387,500,000
Net Change in Cash 449,800,000 751,600,000 -1,751,500,000 161,400,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Operating Activities
Net Income 10,590,000,000 5,240,400,000 6,244,800,000 5,581,700,000 6,193,700,000
Depreciation & Amortization 1,766,600,000 1,527,300,000 1,522,500,000 1,547,600,000 1,323,900,000
Stock Based Compensation 645,600,000 628,500,000 371,100,000 342,800,000 308,100,000
Change in Working Capital -5,385,000,000 -3,055,000,000 -14,500,000 -1,022,600,000 -747,400,000
Operating Cash Flow 8,817,900,000 4,240,100,000 7,084,400,000 7,260,700,000 6,499,600,000
Investing Activities
Capital Expenditure -8,403,600,000 -7,392,100,000 -2,484,000,000 -1,873,200,000 -2,029,100,000
Investments -5,057,800,000 -7,392,100,000 -2,484,000,000 -1,309,800,000 -1,387,900,000
Investing Cash Flow -9,301,500,000 -7,152,700,000 -3,261,600,000 -2,762,300,000 -2,258,900,000
Financing Activities
Debt Repayment 8,901,100,000 -8,649,900,000 -1,560,000,000 -1,905,400,000 -276,500,000
Common Stock Issued/Repurchased -2,500,000,000 -750,000,000 -1,500,000,000 -1,250,000,000 -500,000,000
Dividends Paid -4,680,400,000 -4,069,300,000 -3,535,800,000 -3,086,800,000 -2,687,100,000
Financing Cash Flow 1,230,100,000 3,495,600,000 -5,406,700,000 -4,131,300,000 -3,137,100,000
Summary
Free Cash Flow 414,300,000 -3,152,000,000 4,600,400,000 5,387,500,000 4,470,500,000
Net Change in Cash 449,800,000 751,600,000 -1,751,500,000 161,400,000 1,319,600,000